Urgent Recall: Over 11,000 Bottles of Blood Pressure Medication

UPDATE: Over 11,000 bottles of a widely used blood pressure medication have been urgently recalled due to potential contamination, the U.S. Food and Drug Administration (FDA) announces. The affected product, Bisoprolol Fumarate and Hydrochlorothiazide Tablets, sold under the brand name Ziac, was manufactured by Glenmark Pharmaceuticals Inc.

The recall, which impacts 30-count, 100-count, and 500-count bottles, was initiated on November 21, 2023, after testing revealed traces of ezetimibe, a cholesterol-lowering drug produced by the same manufacturer. The recalled medications were distributed nationwide, prompting immediate action from health authorities.

The specific lot numbers and expiration dates for the recalled bottles are as follows:
– Lot 17232401, exp 11/2025
– Lot 17240974, exp 05/2026

The FDA classified this recall as a Class III risk level on December 1, 2023. A Class III recall indicates that exposure to the product is not likely to cause adverse health consequences, but users are still advised to remain cautious.

Consumers who have purchased these medications should check their bottles immediately and consult with healthcare providers if they have any concerns. The recall remains ongoing as authorities work to ensure the safety of the public.

This urgent development highlights the importance of vigilance when it comes to medications. As more information becomes available, the FDA will continue to update the public on any further actions required. For now, patients are advised to discontinue use of the recalled products and seek alternatives as necessary.

Stay tuned for more updates as this situation develops.